Vaccinations have started at the Institut de Recherche en Sciences de la Sant\u00e9 \u2013 Clinical Research Unit of Nanoro (IRSS-URCN), Burkina Faso for two clinical trials to assess the blood-stage malaria vaccine candidates R78C and RH5.1 with Matrix-M (developed by the Draper Lab in the Department of Paediatrics), in combination with the R21/\u200bMatrix-M vaccine, which targets the earlier liver-stage.
The latest event of the Guest Lecture series welcomed Professor Sarah Stock, Programme Director of In Utero at Wellcome Leap, who delivered a compelling talk titled Breakthroughs in Women\u2019s Health.
Researchers at the MRC Weatherall Institute of Molecular Medicine have developed the first combined human bone and bone marrow organoid platform capable of modelling long-term blood and immune cell production in a fully human 3D system.
A new multinational study from the INTERCOVID Consortium, led by researchers from the University of Oxford, has found that COVID-19 vaccination during pregnancy, particularly when combined with a booster dose, significantly reduces the risk of preeclampsia, a serious and potentially life-threatening pregnancy complication. The findings offer unprecedented insight into preeclampsia prevention, independent of the direct effects of COVID-19 infection.
A new study into visceral leishmaniasis (VL) in Brazil has created the most comprehensive picture of the disease in the country, and highlighted trends including more older patients being diagnosed with the disease and more patients presenting with relapses over time.
An international team of researchers led by the University of Oxford and Oxford University Hospitals NHS Foundation Trust have demonstrated that hospital analysers can be used to identify fake liquid medical products.
Social care for hip fracture costs the NHS over \u00a31.25 billion, equating to \u00a315K per patient every year, according to a new study by the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS).
Researchers from the University of Oxford and international collaborators have developed a new artificial intelligence model that can more accurately predict the medium-term risk of death for people with heart failure using routine electronic health records.
Epilepsy is one of the most common neurological disorders, affecting roughly 50 million people around the world. Researchers at Oxford are looking at how epilepsy can be prevented, diagnosed and treated. Our experts are also raising awareness of the condition to reduce stigma and improve the quality of life for people with epilepsy, particularly those in under-resourced communities.
Researchers from the University of Oxford, including clinicians and scientists from the Nuffield Department of Women\u2019s & Reproductive Health (WRH), have developed a new artificial intelligence (AI) system to assist clinicians during fetal ultrasound scans in real time.
New research finds people experiencing socioeconomic disadvantage are more likely to smoke, more addicted, and less likely to attempt to quit \u2013 a pattern that holds across different types of disadvantage.
Researchers from the Nuffield Department of Women's & Reproductive Health (NDWRH) and the MD Anderson Cancer Center shed light into the egg cell maturation in lizard ovaries by providing a detailed characterisation of the individual stages a reptile egg cell must pass through before it ovulates.
The University of Oxford has received a \u00a31.5 million gift from Bukhman Philanthropies to support new research aiming to tackle one of the most pressing challenges of our time \u2013 young people\u2019s mental health.
In Uganda\u2019s fishing communities, Dr Joseph Matovu is leading a peer-led HIV self-testing project to overcome stigma and healthcare access barriers. With support from the Africa Oxford Initiative (AfOx), the PEST4MEN model empowers local leaders to distribute self-test kits, improving uptake, linkage to care, and community ownership of HIV prevention.
Philanthropic funding from the Friedreich's Ataxia Alliance Innovation Fund awarded to five Oxford researchers to support development of novel therapeutics.
Public support for sharing health data for artificial intelligence (AI) research depends on clear public benefit, strong safeguards, and meaningful consent, according to a new Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) study based on in-depth focus groups with members of the UK public.
Millions of people are now turning to AI chatbots for answers about their health \u2014 but a major new study warns this trust may be misplaced. The largest user study to date examining how large language models (LLMs) support real people making medical decisions finds that these systems can provide inaccurate, inconsistent, and potentially dangerous advice when users seek help with their own symptoms.
![\"Malaria](\"https://www.medsci.ox.ac.uk/news/new-clinical-trials-begin-in-burkina-faso/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n